News
Pearly Penile Papules (PPP): Diagnosis, Treatment, And Prevention
Once you discover that you or your partner has pearly penile papules, it’s easy to feel like it’s the end of the world—this feeling has its roots in the fact that you have little to no knowledge about it....
Drug Research
$300mn Pledged By Novartis For European Biotherapeutics
The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its capabilities and capacity for early technological development of biologics, the multi-year investment will be deployed...
Clinical Trials
US Clinical Trial To Test Antiviral For Monkeypox Starts
In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial assessing the antiviral tecovirimat, better known as TPOXX. The study's researchers hope to include more than 500 participants from...
Clinical Trials
Discoveries About Lumakra Lung Cancer Bolster The KRAS Fight
Amgen is in the lead in a carefully watched race among KRAS inhibitors after winning a lung cancer randomised study. Now, the California drugmaker is giving an early peek at the precise data that might set the benchmark for...
Clinical Trials
EU Officials Make New Work Plan To Speed-Up Clinical Study
The European Commission (EC), Heads of Medicine Agencies (HMA), and European Medicines Agency (EMA) have released the 2022–2026 workplan for the programme Accelerating Clinical Trials in the EU (ACT EU).
Building on the Clinical Trials Regulation (CTR) and Clinical Trials...
Drug Research
Prior To FDA Prurigo Nodularis Ruling, Dupixent Wins Again
Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals this year for the treatment of eosinophilic esophagitis and paediatric eczema, and now the IL-4/IL-13 inhibitor has achieved a...
IT & Data Management
FDA Experts Favor ALS Drug Amylyx, Shifting Former Stance
A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug, increasing the likelihood that the agency will approve it in the coming weeks.
The expert group voted 7-2 in favour...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read